Trial Profile
AXIS IIa - treatment with AX200 for acute ischemic stroke
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Dec 2023
Price :
$35
*
At a glance
- Drugs Filgrastim (Primary)
- Indications Stroke
- Focus Adverse reactions
- Acronyms AXIS-IIa
- 17 Oct 2007 Primary and secondary endpoints achieved; results reported by SYGNIS.
- 22 Jul 2007 Status changed from in progress to completed
- 23 Nov 2006 Status change from Recruiting to In Progress